DRP Journal

Is Corvus Pharmaceuticals (NASDAQ:CRVS) Stock a Better Buy After The Recent Fall?

Corvus Pharmaceuticals (NASDAQ:CRVS) jumped 4% in pre-market but stock is still down 20% in a month. Recently the company announced